Adeno-Associated Viral-Mediated Gene Transfer to Hepatoma: Thymidine Kinase/Interleukin 2 Is More Effective in Tumor Killing in Non-Ganciclovir (GCV)-Treated Than in GCV-Treated Animals

This publication has 22 references indexed in Scilit:

• In VivoTherapy of Hepatocellular Carcinoma with a Tumor-Specific Adenoviral Vector Expressing Interleukin-2
  Human Gene Therapy, 1997
• The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells
  Cancer Letters, 1995
• In situ delivery of suicide genes for cancer treatment
  European Journal Of Cancer, 1994
• Clinical application of immunostimulatory gene transfer
  European Journal Of Cancer, 1994
• lnterleukin-2: Solid-Tumor Therapy
  Oncology, 1994
• Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review
  Cancer Immunology, Immunotherapy, 1993
• Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
  The Journal of Experimental Medicine, 1990
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
  Annual Review of Immunology, 1986
• Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.
  The Journal of Experimental Medicine, 1982